Antonella Nai

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Response to Letter to the Editor: "Advancing TMPRSS6-Targeted Therapy for MASLD: Mechanistic and Translational Perspectives".

Response to Letter to the Editor: "Advancing TMPRSS6-Targeted Therapy for MASLD: Mechanistic and Translational Perspectives".

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 14, 2025

Current Landscape of Hepcidin Therapeutics.

Current Landscape of Hepcidin Therapeutics.

Journal: Advances in experimental medicine and biology

Published: July 02, 2025

Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.

Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 09, 2025

A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates hepcidin expression in vivo.

A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates hepcidin expression in vivo.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: January 22, 2024

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.

Journal: American journal of hematology

Published: November 23, 2023

BMP5: a novel tile of the hepcidin regulatory pathway.

BMP5: a novel tile of the hepcidin regulatory pathway.

Journal: Blood

Published: October 12, 2023

Flavor of Iron at EHA2023: Novel Regulatory Mechanisms and Therapeutic Options for the Correction of Anemia.

Flavor of Iron at EHA2023: Novel Regulatory Mechanisms and Therapeutic Options for the Correction of Anemia.

Journal: HemaSphere

Published: October 06, 2023

Cellular and animal models for the investigation of β-thalassemia.

Cellular and animal models for the investigation of β-thalassemia.

Journal: Blood cells, molecules & diseases

Published: April 21, 2023

Managing the Dual Nature of Iron to Preserve Health.

Managing the Dual Nature of Iron to Preserve Health.

Journal: International journal of molecular sciences

Published: January 15, 2023

FKBP12 inhibits hepcidin expression by modulating BMP receptors interaction and ligand responsiveness in hepatocytes.

FKBP12 inhibits hepcidin expression by modulating BMP receptors interaction and ligand responsiveness in hepatocytes.

Journal: American journal of hematology

Published: November 09, 2022

Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.

Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.

Journal: Blood

Published: August 01, 2022

A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.

A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.

Journal: Kidney international

Published: July 27, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026